Clinical features and outcome of pediatric Wegener's granulomatosis
Open Access
- 25 May 2007
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 57 (5), 837-844
- https://doi.org/10.1002/art.22774
Abstract
Objective Wegener's granulomatosis (WG) is a predominantly small-vessel vasculitis associated with antineutrophil cytoplasmic antibodies (ANCAs). There are few reports describing its clinical features and outcome in children. We report on the experience at a single tertiary referral center over 21 years. Methods We conducted a retrospective chart review of all patients diagnosed with WG at The Hospital for Sick Children between 1984 and 2005. Results Twenty-five patients were identified. Median age at diagnosis and median followup were 14.5 years and 32.7 months, respectively. Male-to-female ratio was 1:4. Median duration of symptoms before diagnosis was 2 months. Of 22 patients, 21 were ANCA positive during their disease course (classic ANCA 78.9%). Constitutional symptoms were the most common clinical feature at presentation (24 of 25). Glomerulonephritis was present in 22 patients at presentation. Only 1 of 11 patients who presented with or developed renal impairment had normalization of serum creatinine. Upper airway involvement occurred in 21 patients at presentation and 24 over followup; only 1 had subglottic stenosis. Twenty patients had initial pulmonary involvement, most commonly nodules (44%) and pulmonary hemorrhage (44%). Five patients required ventilation for pulmonary hemorrhage. Four patients (16%) had venous thrombotic events (VTEs). Treatment included prednisone (100%), cyclophosphamide (76%), azathioprine (40%), and methotrexate (32%). Conclusion Pediatric WG typically presents in adolescence and has a female predominance. Glomerulonephritis and pulmonary disease are common at diagnosis and frequently present as a pulmonary-renal syndrome. Loss of renal function is common and rarely completely reversible. As in adults, children with WG are at risk of VTEs.This publication has 27 references indexed in Scilit:
- Clinical features in 17 paediatric patients with Wegener granulomatosisPediatric Nephrology, 2002
- Design of the Wegener's Granulomatosis Etanercept Trial (WGET)Controlled Clinical Trials, 2002
- Plasmapheresis in Antineutrophil Cytoplasmic Antibodies‐Associated Systemic VasculitisTherapeutic Apheresis, 2001
- Wegener‘s granulomatosis associated with antiphospholipid syndromeLupus, 2000
- Wegener granulomatosis in children and young adultsPediatric Nephrology, 2000
- Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosaArthritis & Rheumatism, 1999
- Small-Vessel VasculitisThe New England Journal of Medicine, 1997
- Wegener granulomatosis in children and adolescents: Clinical presentation and outcomeThe Journal of Pediatrics, 1993
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992
- Wegener granulomatosis in pediatric patientsThe Journal of Pediatrics, 1985